Skip to main content
ASTH
NASDAQ Trade & Services

Q3 Revenue Tops $1B as Net Income Jumps 1,782%, FY Guidance Narrowed

Tom Rudovsky · Reported by PR Newswire
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$39.01
Mkt Cap
$1.935B
52W Low
$18.08
52W High
$51.6
52W Position info
116% above low
Off High info
24% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

ASTH has more than doubled off its 52-week low of $18.08.

Summary

Astrana posted record Q3 revenue of $1,023.6 million, up 7% year over year, with net income attributable to the company of $13.0 million versus $0.4 million a year ago and diluted EPS of $0.26. Adjusted EBITDA rose 13% to $77.2 million, though adjusted EPS of $0.71 was only up 4% from $0.68 — the headline net income jump is largely a low prior-year base, not a step-change in underlying profitability. The company narrowed full-year 2026 guidance to revenue of $3.9-4.0 billion, adjusted EBITDA of $261-274 million and free cash flow of $107.5-130 million, and introduced Q4 revenue guidance of $939-1,039 million. Nine-month operating cash flow of $117.1 million and free cash flow of $105.4 million came in roughly flat versus last year despite the revenue growth, a gap worth pressing management on. This follows the September 8-Ks that reaffirmed FY2026 revenue and free cash flow guidance and the September disclosure of a material cybersecurity incident; the unremediated internal-control weakness flagged in the Q2 10-Q remains an open risk. The 2:30 p.m. PT call today is where guidance cadence and the cash conversion question get tested.

At the time of this announcement, ASTH was trading at $39.01 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $18.08 to $51.60. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

ASTH - Latest Insights

ASTH
Nov 06, 2026, 6:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $39.01
Real-time Price: $28.90 info
Change: -$10.11 (-26%) info
Market Cap: $1.434B info
ASTH
Sep 23, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.11
Real-time Price: $28.90 info
Change: -$6.21 (-18%) info
Market Cap: $1.434B info
ASTH
Aug 10, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $37.47
Real-time Price: $28.90 info
Change: -$8.57 (-23%) info
Market Cap: $1.434B info
ASTH
Aug 06, 2026, 4:39 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $33.70
Real-time Price: $28.90 info
Change: -$4.80 (-14%) info
Market Cap: $1.434B info
ASTH
Aug 06, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.13
Real-time Price: $28.90 info
Change: -$5.23 (-15%) info
Market Cap: $1.434B info